Close

Exact Sciences (EXAS) 'Confusion' Creates Opp, Wedbush Raises to Outperform

October 16, 2013 8:14 AM EDT Send to a Friend
Wedbush upgraded Exact Sciences (NASDAQ: EXAS) from Neutral to Outperform with a price target of $12.00. Analyst Zarak Khurshid thinks ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login